FalconFinance (FF) fluctuated 154.8% in 24 hours: Trading volume surged over 10 times amid whale manipulation suspicions
Bitget Pulse2026/04/11 00:18Brief Volatility Overview
In the past 24 hours, the lowest price for FF reached $0.07076 and peaked at $0.18029 (with the X community recording a high of $0.1764). The current price is $0.10897, showing a volatility amplitude of up to 154.8%. Trading volume surged to approximately $195 million, up more than 1000% compared to the previous day, with a clear sign of net capital inflow.
Brief Analysis of the Causes of Abnormal Movement
- Explosive growth in trading volume: 24-hour turnover soared from the bottom to $164-204 million, an increase of 1073%, which directly fueled sharp price swings.
- Whale and market maker actions: On-chain monitoring by the X community shows that open interest (OI) rose by +24.22%, indicating whale accumulation. Suspicions of “pump-and-dump” patterns by institutions such as DWF Labs led to a short-term surge of 140%-200%.
Market Perspectives and Outlook
X community sentiment is divided: some traders regard it as a “green rocket” with a +77% opportunity, optimistic about continuation but noting it’s overbought (RSI 95.52). The majority warns of a “dead cat bounce” and liquidity trap, expecting a pullback to $0.083-$0.069. They suggest waiting for confirmation of support or taking short-term short positions, highlighting the prominent high-leverage risks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
